T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 15, Issue 8, 2000, Pages 1217-1223

  Sester, Urban ^a   Sester, Martina ^a   Hauk, Michael ^a   Kaul, Harald ^a   Köhler, Hans ^a   Girndt, Matthias ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Haemodialysis; Th1 Th2

Indexed keywords

CD4 ANTIGEN; CYTOKINE; INTERLEUKIN 12;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; INFECTION COMPLICATION; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VACCINATION;

EID: 0033944484     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.8.1217     Document Type: Article

References (26)

1. United States Renal Data System Annual Report. Am J Kidney Dis 1998; 32 [Suppl. 1]: 81-88
2. Köhler H, Arnold W, Renschin G, Dormeyer HH, Meyer zum Büschenfelde KH. Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 1984; 25: 124-128
3. Girndt M, Pietsch M, Köhler H. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 1995; 26: 454-460
4. Meuer SC, Hauer M, Kurz P, Meyer zum Büschenfelde KH, Köhler H. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest 1987; 80: 743-749
5. Girndt M, Köhler H, Schiedhelm Weick E, Meyer zum Büschenfelde KH, Fleischer B. T cell activation defect in haemodialysis patients: evidence for a role of the B7/CD28 pathway. Kidney Int 1993; 44: 359-365
6. Schindler R, Linnenweber S, Schulze M et al. Gene expression of interleukin-1β during hemodialysis. Kidney Int 1993; 43: 712-721
7. Girndt M, Köhler H, Schiedhelm Weick E, Schlaak JF, Meyer zum Büschenfelde KH, Fleischer B. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 1995; 47: 559-565
8. Herbelin A, Nguyen AT, Zingraff J, Urena P, and Descamps-Latscha B. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int 1990; 37: 116-125
9. Betz M, Haensch GM, Rauterberg EW, Bommer J, Ritz E. Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement. Kidney Int 1988; 34: 437-442
10. Ludviksson BR, Sneller MC, Chua KS et al. Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: Reversal with IL-10. J Immunol 1998; 160: 3602-3609
11. Via CS, Handwerger BS. B-cell and T-cell function in systemic lupus erythematosus. Curr Opin Rheumatol 1993; 5: 570-574
12. Swain SL. Helper T cell differentiation. Curr Opin Immunol 1999; 11: 180-185
13. Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: The alternative approaches. Ann Rev Immunol 1997; 15: 297-322
14. Daugirdas JT, Ing TS. Handbook of Dialysis. Little, Brown and Co, Boston, New York: 1994
15. Girndt M, Sester U, Kaul H, Hünger F, Köhler H. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single cell level. J Am Soc Nephrol 1998; 9: 1689-1696
16. Trinchieri G. Immunobiology of interleukin-12. Immunol Res 1998; 17: 269-278
17. Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Ann Rev Immunol 1994; 12: 635-673
18. Dumann H, Meuer S, Meyer zum Büschcnfelde KH, Köhler H. Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure. Kidney Int 1990; 38: 1164-1168
19. Descamps Latseha B, Herbelin A, Nguyen AT et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 1995; 154: 882-892
20. O'Garra A, McEvoy LM, Zlotnik A. T-cell subsets: Chemokine receptors guide the way. Curr Biol 1998; 8: R646-R649
21. Hsieh CS, Macatonia SE, Tripp CS, Wolf SK, O'Garra A, Murphy KM. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 547-549
22. Seder RA, Gazzinelli R, Sher A, Paul WE. IL-12 acts directly on CD4+ T cells to enhance priming for IFNg production and diminish IL-4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90: 10188-10192
23. Nockher WA, Scherberich JE. Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 1998; 66: 2782-2790
24. Dinarello CA. Cytokines: Agents provocateurs in hemodialysis? Kidney Int 1992; 41: 683-694
25. Cavaillon JM, Poignet JL, Fitting C, Delons S. Serum interleukin-6 in long-term hemodialyzed patients. Nephron 1992; 60: 307-313
26. Trinchieri G. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr Opin Immunol 1997; 9: 17-23